$FMBM

F&M BANK CORP (FMBM): Results of Operations and Financial Condition

F&M BANK CORP (FMBM) filed an SEC Form 8-K — Results of Operations and Financial Condition. EX-99.1 2 fmbm_ex991.htm PRESS RELEASE fmbm_ex991.htm EXHIBIT 99.1 FOR RELEASE FOR MORE INFORMATION, CONTACT July 29, 2026 Lisa F. Campbell | EVP | Chief Financial Officer F&M Bank Corp. 540-896-1705 OTCQX: FMBM fmbankva.com F&M BANK CORP. REPORTS SECOND QUARTER 2026 EARNINGS AND

Original reporting
Published Jul 30, 2026, 6:25 PM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Jul 30, 2026, 6:53 PM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
alphai market briefEarnings
Primary signal
$FMBM
Bullish
medium confidence
Mentioned
$FMBM
Relevance
7/10
alphai data visualization · based on SEC EDGAR 8-K
Decision brief

The 30-second read

$FMBMBullishMed
01

Why it matters

Key decision-relevant items are the quantified Q2 earnings, NIM and cost-of-funds changes, credit quality metrics, and the disclosed non-recurring Bearing Insurance sale gain paired with an AFS bond portfolio restructuring that produced a pre-tax loss.

02

Market read

The filing updates traders on earnings quality (non-recurring items), profitability drivers (NIM, net interest income), and credit risk (NPA and net charge-offs) for FMBM.

03

What to watch

Traders may underweight the magnitude of the AFS yield repositioning (1.66% to 4.92% with a $3.5M pre-tax loss) and how that affects future net interest margin and unrealized AFS mark-to-market volatility.

Relevance 7/10Novelty 7/10Timing: filed after-hours on 2026-07-30, covering Q2 2026 results

Background

This SEC 8-K (Item 2.02) reports F&M Bank Corp’s second-quarter 2026 results and includes an exhibit press release with detailed financial metrics and balance-sheet actions.

Company-level read

Ticker impact

$FMBMBullishMedium confidence
Context

F&M Bank Corp reported Q2 2026 net income of $5.37M and disclosed a Bearing Insurance sale gain plus a bond-portfolio restructuring loss.

Expected impact

Near-term bias modestly positive, with traders likely focusing on whether the one-time Bearing gain is offset by the bond restructuring loss and how NIM and asset quality trend.

Evidence & confidence

The 8-K includes quantified quarterly results (net income, EPS, NIM, ROAA/ROAE, asset quality) and specific non-recurring transactions (Bearing sale gain and AFS yield swap causing a pre-tax loss).

Market effects

OTCQX community bank earnings with disclosed NIM and credit-loss provision trends can inform read-across for similarly sized regional lenders.

Primarily impacts sentiment around Virginia community banking footprint and local deposit/loan growth dynamics.

Low; this is a small-cap bank-specific earnings and balance-sheet management update.

Counterpoint

The headline strength is partly driven by non-recurring Bearing Insurance sale proceeds, so normalized earnings power may be lower than the quarter’s headline net income suggests.

Key entities

  • F&M Bank Corp

    OTCQX-listed parent company reporting Q2 2026 results and non-recurring Bearing Insurance sale and bond portfolio restructuring.

  • Bearing Insurance

    Richmond-based insurance ownership interest sold in April 2026, generating a one-time pre-tax gain of $4.8M.

  • Farmers & Merchants Bank

    Operating bank referenced as the company’s banking entity in the earnings release.

Related articles

$MURMedAI 8/10

Murphy Oil Sees Sharp Profit Increase

Murphy Oil Corp reported Q2 2026 adjusted net income of $225.8 million, nearly six times Q2 2025, as higher oil prices offset lower production and weaker gas. Adjusted EPS was $1.55 vs $1.51 consensus. Revenue rose to $926.3 million. Murphy kept its $0.35 dividend and raised 2026 capex midpoint to $1.55 billion.

$GSBDMed

Goldman Sachs BDC Q2 Earnings Call Highlights

Goldman Sachs BDC (NYSE:GSBD) reported no incentive fee in Q2, citing its three-year total-return lookback provision. NAV was $12.06/share at June 30 vs $12.17 in Q1. The board declared a Q3 base dividend of $0.32/share plus $0.03 supplemental. Investments were $3.2B fair value, non-accrual 2.9%, and net debt-to-equity 1.35x.

$HBBMed

Hamilton Beach Brands Q2 Earnings Call Highlights

Hamilton Beach Brands (HBB) reported Q2 gross margin of 26.1% excluding tariff-related benefits, and said it expects 2026 revenue growth in the mid-single-digit range. Management forecast full-year gross margin to improve modestly and operating profit to decline by a high-single-digit percentage. Operating cash flow is expected at $35M to $45M. HBB ended with net cash of $51.5M.

$GXOMed

GXO Logistics Q2 Earnings Call Highlights

GXO Logistics reported Q2 results and said it secured over $1 billion in expected incremental new-business revenue for 2026 and about $353 million for 2027. Management cited a $2.7 billion sales pipeline after quarter end. Operating cash flow was $76 million, free cash flow positive $12 million, cash $769 million, and net leverage 2.6x. GXO plans to target EBIT margins above 6% and deploy AI across ~50 sites in 2026.

$GRNDMed

Grindr Q2 Earnings Call Highlights

Grindr (NYSE:GRND) said free users remain central to its strategy, while AI tools are boosting engineering productivity. Management estimated engineering output rose about 2.5x from July 2025 to April 2026 with similar headcount, supporting a 39% to 42% adjusted EBITDA margin outlook. EDGE AI premium tier rollout is planned for later in fall; operating expenses ex cost of revenue were $71M vs $53M.

$HAEMedAI 8/10

Haemonetics Q1 Earnings Call Highlights

Haemonetics (NYSE:HAE) reported Q1 interventional technologies returning to 3% organic growth, with vascular closure led by VASCADE MVP and MVP XL momentum in the U.S. Apheresis revenue rose 6% organically to $191M and plasma revenue grew 8% organically as Persona PLUS rollout accelerates. Haemonetics raised FY2027 revenue guidance to 5% to 8% reported and 4% to 7% organic.